BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34499698)

  • 1. Biofilm regulation in Clostridioides difficile: Novel systems linked to hypervirulence.
    Taggart MG; Snelling WJ; Naughton PJ; La Ragione RM; Dooley JSG; Ternan NG
    PLoS Pathog; 2021 Sep; 17(9):e1009817. PubMed ID: 34499698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile.
    Ðapa T; Leuzzi R; Ng YK; Baban ST; Adamo R; Kuehne SA; Scarselli M; Minton NP; Serruto D; Unnikrishnan M
    J Bacteriol; 2013 Feb; 195(3):545-55. PubMed ID: 23175653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridioides difficile Biofilm.
    Vuotto C; Donelli G; Buckley A; Chilton C
    Adv Exp Med Biol; 2024; 1435():249-272. PubMed ID: 38175479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular DNA, cell surface proteins and c-di-GMP promote biofilm formation in Clostridioides difficile.
    Dawson LF; Peltier J; Hall CL; Harrison MA; Derakhshan M; Shaw HA; Fairweather NF; Wren BW
    Sci Rep; 2021 Feb; 11(1):3244. PubMed ID: 33547340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of single and mixed biofilms in
    Zhong S; Yang J; Huang H
    Crit Rev Microbiol; 2024 May; 50(3):285-299. PubMed ID: 36939635
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative biofilm-forming ability between
    Morais MLGDS; Santos MGC; Costa CL; Martins CS; Leitão RFC; de Melo Pacífico D; Quesada-Gómez C; Castelo Branco D; Ferreira EO; Brito GAC
    Front Cell Infect Microbiol; 2022; 12():1033698. PubMed ID: 36619751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revealing roles of S-layer protein (SlpA) in
    Wang S; Courreges MC; Xu L; Gurung B; Berryman M; Gu T
    Microbiol Spectr; 2024 Jun; 12(6):e0400523. PubMed ID: 38709045
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of Type IV Pili Contributes to Surface Behaviors of Historical and Epidemic Strains of Clostridium difficile.
    Purcell EB; McKee RW; Bordeleau E; Burrus V; Tamayo R
    J Bacteriol; 2016 Feb; 198(3):565-77. PubMed ID: 26598364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates.
    Tijerina-Rodríguez L; Villarreal-Treviño L; Baines SD; Morfín-Otero R; Camacho-Ortíz A; Flores-Treviño S; Maldonado-Garza H; Rodríguez-Noriega E; Garza-González E
    PLoS One; 2019; 14(7):e0220671. PubMed ID: 31365590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection.
    Normington C; Moura IB; Bryant JA; Ewin DJ; Clark EV; Kettle MJ; Harris HC; Spittal W; Davis G; Henn MR; Ford CB; Wilcox MH; Buckley AM
    NPJ Biofilms Microbiomes; 2021 Feb; 7(1):16. PubMed ID: 33547298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of Clostridium difficile and human microbiota.
    Crowther GS; Chilton CH; Todhunter SL; Nicholson S; Freeman J; Baines SD; Wilcox MH
    PLoS One; 2014; 9(2):e88396. PubMed ID: 24516647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofilm formation by Clostridium difficile.
    Dapa T; Unnikrishnan M
    Gut Microbes; 2013; 4(5):397-402. PubMed ID: 23892245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual role of the colonization factor CD2831 in Clostridium difficile pathogenesis.
    Arato V; Gasperini G; Giusti F; Ferlenghi I; Scarselli M; Leuzzi R
    Sci Rep; 2019 Apr; 9(1):5554. PubMed ID: 30944377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusobacteriumnucleatum Adheres to Clostridioides difficile via the RadD Adhesin to Enhance Biofilm Formation in Intestinal Mucus.
    Engevik MA; Danhof HA; Auchtung J; Endres BT; Ruan W; Bassères E; Engevik AC; Wu Q; Nicholson M; Luna RA; Garey KW; Crawford SE; Estes MK; Lux R; Yacyshyn MB; Yacyshyn B; Savidge T; Britton RA; Versalovic J
    Gastroenterology; 2021 Mar; 160(4):1301-1314.e8. PubMed ID: 33227279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic-di-GMP signaling in the Gram-positive pathogen Clostridium difficile.
    Bordeleau E; Burrus V
    Curr Genet; 2015 Nov; 61(4):497-502. PubMed ID: 25800812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of Clostridium difficile biofilm formation, a role for Spo0A.
    Dawson LF; Valiente E; Faulds-Pain A; Donahue EH; Wren BW
    PLoS One; 2012; 7(12):e50527. PubMed ID: 23236376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hype or hypervirulence: a reflection on problematic C. difficile strains.
    Smits WK
    Virulence; 2013 Oct; 4(7):592-6. PubMed ID: 24060961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Regulatory Mechanisms Control the Production of CmrRST, an Atypical Signal Transduction System in Clostridioides difficile.
    Garrett EM; Mehra A; Sekulovic O; Tamayo R
    mBio; 2021 Feb; 13(1):e0296921. PubMed ID: 35164558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida gut colonization, yeast species distribution, and biofilm production in Clostridioides difficile infected patients: a comparison between three populations in two different time periods.
    Brunetti G; Giuliani A; Navazio AS; Paradisi C; Raponi F; Conti LA; Raponi G
    Braz J Microbiol; 2021 Dec; 52(4):1845-1852. PubMed ID: 34264501
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Furtado KL; Plott L; Markovetz M; Powers D; Wang H; Hill DB; Papin J; Allbritton NL; Tamayo R
    mSphere; 2024 Jun; 9(6):e0008124. PubMed ID: 38837404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.